Rob Garver, MD
Rob Garver (RG) is the founder of SEC Clinical Research, and serves as Principal Investigator on all studies at this time. RG is a graduate of the Johns Hopkins School of Medicine, completing his residency at the Johns Hopkins Hospital. Fellowships for Pulmonary Disease, and later for Critical Care Medicine, were performed at the National Institutes of Health and UAB School of Medicine, respectively, and he is board certified in Pulmonary Disease, Critical Care Medicine and Internal Medicine. He was a Professor of Medicine in the Pulmonary and Critical Care Medicine Division at UAB School of Medicine. After 20 years in academics, RG joined a large private practice pulmonary group, and shortly thereafter established his own solo practice in Andalusia Alabama called SEC Lung (see LINK: SEC Lung
Clinical research studies were added to the activities of SEC Lung with the assistance of an SMO in late 2012. In early 2014, RG amicably parted ways with the SMO in order to grow and develop an independent clinical research program. Based on his academic background, RG was able to rapidly expand the clinical research enterprise and established SEC Clinical Research in 2016 – also opening a second clinical research site in Dothan Alabama. RG has since restricted his clinical practice in order to have ample time for the expanded research commitments.